These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18389902)

  • 1. Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors.
    Loutfy MR; Macdonald S; Myhr T; Husson H; Du Mont J; Balla S; Antoniou T; Rachlis A
    Antivir Ther; 2008; 13(1):87-95. PubMed ID: 18389902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana.
    Tetteh RA; Nartey ET; Lartey M; Mantel-Teeuwisse AK; Leufkens HG; Nortey PA; Dodoo AN
    BMC Public Health; 2015 Jun; 15():573. PubMed ID: 26092496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postexposure prophylaxis for HIV after sexual assault.
    Myles JE; Hirozawa A; Katz MH; Kimmerling R; Bamberger JD
    JAMA; 2000 Sep; 284(12):1516-8. PubMed ID: 11000643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center.
    Neu N; Heffernan-Vacca S; Millery M; Stimell M; Brown J
    Sex Transm Dis; 2007 Feb; 34(2):65-8. PubMed ID: 16794560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-occupational postexposure prophylaxis for HIV: a systematic review.
    Bryant J; Baxter L; Hird S
    Health Technol Assess; 2009 Feb; 13(14):iii, ix-x, 1-60. PubMed ID: 19236820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims.
    Malinverni S; Bédoret F; Bartiaux M; Gilles C; De Wit S; Libois A
    Sex Transm Infect; 2021 Aug; 97(5):329-333. PubMed ID: 33106437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims.
    Olshen E; Hsu K; Woods ER; Harper M; Harnisch B; Samples CL
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):674-80. PubMed ID: 16818831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual Assault and HIV Postexposure Prophylaxis at an Urban African Hospital.
    Muriuki EM; Kimani J; Machuki Z; Kiarie J; Roxby AC
    AIDS Patient Care STDS; 2017 Jun; 31(6):255-260. PubMed ID: 28605228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial).
    Milinkovic A; Benn P; Arenas-Pinto A; Brima N; Copas A; Clarke A; Fisher M; Schembri G; Hawkins D; Williams A; Gilson R;
    J Antimicrob Chemother; 2017 Jun; 72(6):1760-1768. PubMed ID: 28369381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-exposure prophylaxis for human immunodeficiency virus after sexual assault in a Midwestern U.S. emergency department.
    Cherabie JN; Gleason E; Munigala S; Fox B; Trolard A; McCammon C; Hilbert S; Casabar E; Reno H; Liang SY
    Am J Emerg Med; 2021 Nov; 49():117-123. PubMed ID: 34102456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV postexposure prophylaxis use among Ontario female adolescent sexual assault victims: a prospective analysis.
    Du Mont J; Myhr TL; Husson H; Macdonald S; Rachlis A; Loutfy MR
    Sex Transm Dis; 2008 Dec; 35(12):973-8. PubMed ID: 18836390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive care and HIV prophylaxis after sexual assault in rural South Africa: the Refentse intervention study.
    Kim JC; Askew I; Muvhango L; Dwane N; Abramsky T; Jan S; Ntlemo E; Chege J; Watts C
    BMJ; 2009 Mar; 338():b515. PubMed ID: 19286746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection.
    Rabaud C; Burty C; Grandidier M; Christian B; Penalba C; Béguinot I; Jeanmaire H; May T
    Clin Infect Dis; 2005 Jan; 40(2):303-5. PubMed ID: 15655751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postexposure prophylaxis after sexual assaults: a prospective cohort study.
    Garcia MT; Figueiredo RM; Moretti ML; Resende MR; Bedoni AJ; Papaiordanou PM
    Sex Transm Dis; 2005 Apr; 32(4):214-9. PubMed ID: 15788918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV post-exposure prophylaxis after sexual assault: the experience of a sexual assault service in London.
    Limb S; Kawsar M; Forster GE
    Int J STD AIDS; 2002 Sep; 13(9):602-5. PubMed ID: 12230923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The uptake of HIV post-exposure prophylaxis within a sexual assault setting in Sydney, Australia.
    Templeton DJ; Davies SC; Garvin AL; Garsia RJ
    Int J STD AIDS; 2005 Feb; 16(2):108-11. PubMed ID: 15807937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. South african sexual assault survivors' experiences of post-exposure prophylaxis and individualized nursing care: a qualitative study.
    Arend E; Maw A; de Swardt C; Denny LA; Roland M
    J Assoc Nurses AIDS Care; 2013; 24(2):154-65. PubMed ID: 22835505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV post-exposure prophylaxis provided at an urban paediatric emergency department to female adolescents after sexual assault.
    Merchant RC; Keshavarz R; Low C
    Emerg Med J; 2004 Jul; 21(4):449-51. PubMed ID: 15208228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of HIV post-exposure prophylaxis in forensic medicine following incidents of sexual violence in Hamburg, Germany: a retrospective study.
    Ebert J; Sperhake JP; Degen O; Schröder AS
    Forensic Sci Med Pathol; 2018 Sep; 14(3):332-341. PubMed ID: 29777425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piloting post-exposure prophylaxis in Kenya raises specific concerns for the management of childhood rape.
    Speight CG; Klufio A; Kilonzo SN; Mbugua C; Kuria E; Bunn JE; Taegtmeyer M
    Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):14-8. PubMed ID: 16225898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.